Phase 2b study evaluating diagnostic performance of 18F-RAD101 for suspected recurrent brain metastases from solid tumors of different origins Underscores Radiopharm’s commitment to developing...
/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE U.S./ Source Rock Royalties Ltd. (‘Source Rock’) (TSXV: SRR), a pure-play oil...
Q1 2025 Operational and Financial Highlights Gold equivalent ounce (‘GEO’) production of 9,082 GEOs and sales of 8,034 GEOs for Q1 2025. The Company...